{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-004096","form_type":"8-K","ticker":"BCRX","cik":"0000882796","company_name":"BIOCRYST PHARMACEUTICALS INC","filed_at":"2026-06-12T20:10:10+00:00","discovered_at":"2026-06-12T20:12:00.360467+00:00","generated_at":"2026-06-12T20:23:14.923504+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BioCryst shareholders approve 7M share increase to Stock Incentive Plan","bullets":["Incentive Plan approved with 119.8M for, 63.3M against, adding 7M shares to the Plan.","Directors Heggie, McKee, Stonehouse re-elected; each received >170M votes for.","Non-binding say-on-pay passed but 56.8M (31% of votes cast) voted against.","Ernst & Young ratified as 2026 auditor with 210.3M votes for, 7.2M against.","34.0M broker non-votes recorded on director elections, say-on-pay, and plan vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-004096","json":"https://secwatch.observer/filing/0001171843-26-004096.json","markdown":"https://secwatch.observer/filing/0001171843-26-004096.md","text":"https://secwatch.observer/filing/0001171843-26-004096.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882796/000117184326004096/0001171843-26-004096-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882796/000117184326004096/f8k_061226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T20:23:14.923504+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}